2 news items
TriLink BioTechnologies collaborates with Johns Hopkins University to establish a new RNA Innovation Center
MRVI
13 May 24
in oncology, infectious diseases, cardiology, and neurological disorders, to enabling future pandemic response plans
TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance Production
MRVI
18 Apr 24
at warp speed, to empowering innovative treatments in oncology, infectious diseases, cardiology, and neurological disorders, to enabling future pandemic
- Prev
- 1
- Next